ePrints

Intranasal administration of recombinant Human Cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: A Phase II, multicenter, double-blind, randomized, placebo-controlled, parallel group dose-finding trial

Lookup NU author(s): Professor Jaap Van Laar

Downloads

• Published version [.pdf]

Publication metadata

Author(s): Landewe RB, Houbiers JG, van den Bosch FE, In't Hout J, Verschueren PC, Meijerink JH, van den Hoogen FH, Masek BA, Bruyn GA, Wouters JM, Voskuyl AE, van Laar JM, Bijlsma JJ, van der Heijde DM, Breedveld FC, van de Putte LB, Miltenburg AM, de Keyser F

Publication type: Article

Publication status: Published

Journal: Annals of the Rheumatic Diseases

Year: 2010

Volume: 69

Issue: 9

Pages: 1655-1659

Date deposited: 03/06/2010

ISSN (print): 0003-4967

ISSN (electronic): 1468-2060

Publisher: BMJ Group

URL: http://dx.doi.org/10.1136/ard.2009.117234

DOI: 10.1136/ard.2009.117234

Altmetrics

Share